Pricing Log in Create free account
Saturday 17 October 2026 Export CAH’s income statement to Excel — free account

Cardinal Health, Inc.

CAH Healthcare Medical Distribution

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

254.06 0.35 +0.14%
Market cap
$58.8B
P/E
35.0×
Fwd P/E
23.3×
Dividend yield
0.81%
F-score
7/9
Altman Z
5.09
Beneish M
−2.74
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cardinal Health, Inc. (CAH) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Cardinal Health, Inc. (CAH) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.1× (July 2022) to 0.3× (March 2015); the current reading is higher than 89% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 0.2× 16.57%
FY2025 0.2× 92.41%
FY2024 0.1× (14.66%)
FY2023 0.1× 47.55%
FY2022 0.1× (30.25%)
FY2021 0.1× (4.91%)
FY2020 0.1× (7.07%)
FY2019 0.1× (17.90%)
FY2018 0.2× (23.81%)
FY2017 0.2× (8.05%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.2× 8.49%
Mar 2026 0.2× (2.64%)
Dec 2025 0.2× 25.45%
Sep 2025 0.2× (12.03%)
42 more quarters

Against its own ten years

Low 0.1× High 0.3×
Ten-year median 0.2×
Current reading's percentile 97

EV/Sales against peers

Company EV/Sales
HKPD Cellyan Biotechnology Co., Ltd compare n/m
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. 0.3×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. compare 0.9×
AHG Akso Health Group Sponsored ADR compare 1.8×
FOCL FocalTherics compare 2.1×
Medical Distribution industry median 0.6×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CAH